Prediction of tumor progression in intermediate and advanced hepatocellular carcinoma undergoing TACE combined with targeted immunotherapy
{{output}}
Background: Transcatheter arterial chemoembolization (TACE) combined with targeted immunotherapy have become the standard first-line treatment strategy for intermediate and advanced hepatocellular carcinoma (HCC), but some patien... ...
